文献速递产科母胎医学

三胎妊娠产前cfDNA筛查的临床实验室经验

Clinical Laboratory Experience With Prenatal cfDNA Screening in Triplet Pregnancies.
PubMed 文献 · Prenat Diagn · 2025-05-08

该研究回顾性分析超过1500份三胎妊娠cfDNA筛查样本,平均年龄34岁、平均孕周13周,最常见指征为孕妇年龄(>60%)。13例(1.01%)筛查阳性,270例(17.32%)无结果,147份样本获完整或部分结局信息,未发现假阳性或假阴性。结论支持cfDNA筛查在三胎妊娠中是合理选择,性能可能接近双胎妊娠但无结果率更高。

要点

  • 三胎妊娠cfDNA筛查平均年龄34岁、平均孕周13周,主要指征为孕妇年龄。
  • 筛查阳性率1.01%(13例),无结果率17.32%(270例)。
  • 147份样本获结局信息,未发现假阳性或假阴性。

核心结论

  • 研究数据支持在三胎妊娠中cfDNA筛查是合理方法,因缺乏替代筛查选择,且性能可能接近双胎妊娠但无结果率更高。

研究设计与样本

  • 回顾性综述,分析超过1500份三胎妊娠cfDNA筛查常见非整倍体的样本。

主要发现

  • 平均患者年龄34岁,平均孕周13周。
  • 最常见检测指征为孕妇年龄,占队列>60%。
  • 13例筛查阳性(1.01%),270例无结果(17.32%),其余为筛查阴性。
  • 147份样本获得完整或部分遗传学和/或产科结局信息(包括出生和新生儿结局),包括全部13例阳性样本。
  • 未发现假阳性或假阴性病例。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Prenatal cfDNA screening is the most sensitive and specific screen for common aneuploidies in singleton and twin pregnancies and has been endorsed by several professional societies as a first-tier screen or contingent screen. However, data for triplet pregnancies is lacking, as these pregnancies are relatively uncommon and obtaining sufficient data for a robust analysis of test performance is challenging. METHOD: This study presents a retrospective review of over 1500 samples from triplet pregnancies screened via cfDNA for common aneuploidies. RESULTS: Mean patient age was 34 years, while mean gestational age was 13 weeks. The most common indication for testing was patient age, representing > 60% of the cohort. There were 13 screen-positive cases (1.01%), 270 NR cases (17.32%), and the remainder were screen-negative. Complete or partial genetic and/or obstetric outcome information (including birth and neonatal outcomes) was available for 147 samples, including all 13 positive cfDNA samples. No false positive or false negative cases were identified. CONCLUSION: The data from this study support the notion that cfDNA screening in triplet pregnancies is a reasonable approach given the lack of alternative screening options for these patients and that the performance likely approaches that of twin pregnancies, albeit with a higher no-call rate.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Soster E, Dyr B, Caldwell S, et al. Clinical Laboratory Experience With Prenatal cfDNA Screening in Triplet Pregnancies. Prenat Diagn. 2025. PMID: 40344231. doi:10.1002/pd.6812

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。